The News
Varioptic S.A and The Dow Chemical Company (TDCC) to Collaborate for the Development of New Generation Products
10/10/2006
Lyon, 10 October 2006 – Varioptic S.A and The Dow Chemical Company (NYSE: DOW) announced today that they will combine their strength and expertise to bring new developments in the field of electrowetting technology for Liquid Lenses.
The results of this partnership will significantly improve optical, chemical and physical performance of Varioptic’s liquid lenses, broadening the range of applications for liquid lens products.
“Varioptic has considerable background experience in the development of proprietary materials for liquid lens applications and significant progress has been made recently to design reliable liquid formulations for mobile phone camera modules” says Paul Morris, director, Dow Venture Capital “As Varioptic moves forward from AutoFocus applications to other applications (such as microzoom) the requirements are even more challenging. We consider TDCC’s capability in high throughput screening to be a powerful tool in helping optimize electrowetting performance for such requirements. We believe that Varioptic’s technology can become a major component of the evolution of mobile phones and we are happy to start this cooperation”.
“The market for optical solutions in mobile phones and PDAs is poised for exponential growth, and the partnership we’ve announced today will help accelerate the development and delivery of numerous applications” says Jean-Christophe Robert, CTO of Varioptic “Combining our companies’ expertise will open up new opportunities in a wide range of applications that can benefit from such optical solutions and we are looking forward to working with TDCC to capitalize on this enormous market opportunity”
About Dow Venture Capital
Dow Venture Capital has invested over 0 million in businesses based on Life Sciences & Biotechnology; Communications & Information Technology; and Physical Sciences. Dow invests, in part, through institutional venture capital firms, and also directly in start-up companies. The Dow Venture Capital team has developed a broad network of VC partners that specialize in Dow's targeted investment markets and geographies. Dow Venture Capital's investment professionals are widely experienced in discovering new investment opportunities, and supporting portfolio companies. Territories in which Dow is actively managing investments include North America, Europe and Asia.
About Varioptic
Varioptic pioneers in designing and manufacturing electrically controlled optical liquid lenses for optical designers. In order to maintain its technology leadership, Varioptic heavily invests in R&D for the further development of innovative products for various applications. Founded in 2002, Varioptic is located in Lyon (France) and headed by Etienne Paillard, CEO. Press contacts:
Isabelle Jourdain, Communication Manager Philippe Ruffin, Product Marketing Manager
Isabelle.jourdain@varioptic.com philippe.ruffin@varioptic.com
Phone : +33 (0)4 50 32 36 01 Phone : +33 (0)4 37 65 19 35
2006
-
18/01/2006
Ablynx announces pharma alliance to develop therapeutic Nanobodies™
-
23/01/2006
Sofinnova et Apax Partners investissent 12 millions d'euros dans DBV Technologies
-
23/01/2006
Sofinnova and Apax Partners invest €12 million in DBV Technologies
- 24/01/2006
-
24/01/2006
Emailvision files for an IPO on the Euronext Paris Alternext stock market.
-
24/01/2006
Varioptic announces general availability of the Artic 320 liquid lens for camera-phones
- 24/01/2006
- 24/01/2006
- 31/01/2006
- 03/02/2006
-
03/02/2006
Sofinnova Partners takes two prizes in prestigious EVJC awards event
-
03/02/2006
La richesse et les performances Java d’Esmertec à présent disponibles sur AJAR de TTPCom
- 03/02/2006
-
08/02/2006
Emailvision Announces Successful IPO On Euronext Paris Alternext Market.
- 08/02/2006
-
13/02/2006
Lectus Therapeutics closes Series A funding round raising £8.2 million
- 15/02/2006
-
01/03/2006
CoreValve names J. C. MacRae as Vice President of Finance and Chief Financial Officer
-
28/02/2006
Faust Pharmaceuticals nomme Thomas C. Seoh au poste de directeur général
-
02/03/2006
NicOx conclut un nouvel accord majeur avec Pfizer pour des composés donneurs de NO en ophtalmologie
-
02/03/2006
NicOx signs major new agreement with Pfizer for NOdonating compounds in ophthalmology
- 09/03/2006
- 14/03/2006
- 14/03/2006
-
14/03/2006
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel
- 24/03/2006
- 27/03/2006
- 28/03/2006
-
28/03/2006
Diatos Announces Expansion of Medarex Cancer Product Licensing Agreement
-
24/03/2006
Esmertec apporte au marché M2M une solution logicielle client-serveur unique – OSVM Universe
- 28/03/2006
-
10/04/2006
Endoart SA Completes US$ 10.5 million (CHF 13.5 million) Venture Financing Round
- 26/04/2006
-
26/04/2006
Endoart's remote-controlled gastric band gets .5m injection of private money
- 19/04/2006
-
02/05/2006
Barrett Katz, MD, MBA, Appointed EVP & CMO of Fovea Pharmaceuticals
- 27/04/2006
- 27/04/2006
-
25/04/2006
Varioptic lève 16.4 millions d’euros ($20m) pour son troisième tour de table
-
25/04/2006
Varioptic Secures € 16.4 million (USD 20m) in Third Round of Financing
-
19/04/2006
Fidelity Investments International acquiert près de 10% du capital d’Emailvision
- 04/05/2006
- 04/05/2006
-
03/05/2006
Cotherix Inc. : Net Sales Increase 32 Percent Over Previous Quarter
- 10/05/2006
-
11/05/2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome® from Gilead Sciences
- 11/05/2006
- 09/05/2006
- 11/05/2006
- 15/06/2006
- 15/05/2006
- 02/05/2006
-
10/05/2006
Samsung selects 6Wind software to develop mobile IP applications
-
10/05/2006
Samsung selectionne 6Wind pour développer des applications de mobilité IP
- 17/05/2006
- 18/05/2006
- 16/05/2006
- 03/05/2006
- 18/05/2006
-
18/05/2006
Prévision d'une baisse importante du chiffre d'affaires au premier semestre 2006
-
17/05/2006
BASF Plant Science acquires Belgian biotechnology company CropDesign.
- 29/05/2006
-
11/05/2006
Diatos Annonce l’Acquisition du Médicament Oncologique DaunoXome® auprès de Gilead Sciences
-
11/05/2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome® from Gilead Sciences
-
06/06/2006
Varioptic finalise son tour de table avec la participation de Dow Corporate Venture Capital
- 06/06/2006
- 13/06/2006
-
15/05/2006
UPEK Recognized as 2006 Laureate by The Computerworld Honors Program
- 19/06/2006
- 28/06/2006
- 08/06/2006
-
07/07/2006
Varioptic etend sa gamme de solutions autofocus avec Artic 416
- 06/07/2006
- 02/08/2006
- 02/08/2006
- 17/07/2006
- 17/07/2006
- 29/08/2006
-
28/08/2006
Travel Meta Search receives financing round from Sofinnova Partners and Walden International
-
30/08/2006
Esmertec announces results for the half-year ended June 30, 2006
-
30/08/2006
Addex commences Phase II clinical trials programme with ADX10059
- 05/09/2006
- 23/08/2006
- 23/08/2006
- 11/09/2006
- 11/09/2006
- 11/09/2006
- 26/09/2006
- 05/10/2006
-
05/10/2006
WYPLAY SAS reçoit un financement de 4 millions d’euros de la part de Sofinnova Partners
-
05/10/2006
WYPLAY SAS receives €4 million financing round from Sofinnova Partners
- 09/10/2006
- 09/10/2006
-
09/10/2006
Esmertec annonce la cession de sa participation majoritaire dans sa filiale japonaise
-
09/10/2006
Esmertec Announces Sale of Majority Stake in Japanese Subsidiary
- 10/10/2006
- 10/10/2006
-
10/10/2006
Varioptic S.A and The Dow Chemical Company (TDCC) to Collaborate for the Development of New Generation Products
-
17/10/2006
Inside Contactless selected as finalist to receive cartes 2006 Best Hardware sesame award
- 19/10/2006
-
16/10/2006
UPEK Receives First FIPS 201 Certification for Silicon Fingerprint Sensors
- 20/10/2006
- 20/10/2006
-
18/10/2006
VoluBill signs new deal with major mobile operator in Northern Africa
- 24/10/2006
- 24/10/2006
-
24/10/2006
Corevalve's 18-french revalving™ system demonstrated 'live' at TCT 2006
-
02/11/2006
Launch of Blyk Heralds a New Opportunity in Mobile Advertising
- 06/11/2006
- 06/11/2006
- 13/11/2006
-
13/11/2006
Cerenis Therapeutics clôt un tour de financement record de 42.1 millions d'euros
- 13/11/2006
-
13/11/2006
Initial Clinical Experience with Telemetrically Adjustable Gastric Banding
- 21/11/2006
- 21/11/2006
-
30/11/2006
Esmertec’s Jbed Software Deployed in LG Electronics’ Highly Successful GSM-based Chocolate Phone
-
05/12/2006
Esmertec and Yuhua TelTech Set New Benchmark with 1-stop Solution for Linux®-Based Mobile Devices
- 21/12/2006
- 22/02/2006
-
21/02/2006
Stentys appoints Luc Morisset as Director of Regulatory Affairs
- 28/02/2006